Neurovision Medical Products, Inc. v. Medtronic Public Limited Company et al, No. 2:16-cv-00127 (E.D. Tex. Apr. 5, 2017)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
The parties in this patent infringement action appeared to have settled their dispute, but the final settlement agreement fell through when Defendants learned that the Patent Trial and Appeal Board (PTAB) instituted inter partes review (IPR) of one of the asserted patents . Neurovision Medical Products, Inc. (“Neurovision”) now seeks emergency relief to enforce the parties’ settlement agreement. ECF No. 102.
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error